Voltar
Artigo Acesso aberto Revisado por pares
BIBTEX RIS

Amifostine Protects Against Cisplatin-Induced Ototoxicity in Children With Average-Risk Medulloblastoma

2008; Lippincott Williams & Wilkins; Volume: 26; Issue: 22 Linguagem: Inglês

10.1200/jco.2007.14.3974

ISSN

1527-7755

Autores

Maryam Fouladi, Murali Chintagumpala, David M. Ashley, Stewart J. Kellie, Sridharan Gururangan, Tim Hassall, Lindsey Gronewold, Clinton F. Stewart, Dana Wallace, Alberto Broniscer, Gregory A. Hale, Kimberly A. Kasow, Thomas E. Merchant, B. Morris, Matthew J. Krasin, Larry E. Kun, James M. Boyett, Amar Gajjar,

Tópico(s)

Lung Cancer Research Studies

Resumo

To determine the role of amifostine as a protectant against cisplatin-induced ototoxicity in patients with average-risk (AR) medulloblastoma treated with craniospinal radiotherapy and four cycles of cisplatin-based, dose-intense chemotherapy and stem-cell rescue.

Referência(s)